A Study of GSK256073 in Subjects With Type 2 Diabetes Mellitus Who Are Being Treated With Metformin

NCT01376323 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

92

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: GSK256073 1mg
DRUG: GSK256073 5mg
DRUG: GSK256073 10mg
DRUG: GSK256073 25mg
DRUG: Placebo
DRUG: Sitagliptin 100mg

Sponsor

GlaxoSmithKline